1.    Committee Business

·         Call to order

·         Approval of the minutes of the May 19, 2026, meeting

 

2.    Utah Department of Agriculture and Food Inventory Control System Implementation Update

The Utah Department of Agriculture and Food (UDAF) oversees the inventory control system in accordance with UCA 4-41a-103. UDAF will brief the working group on the status of the inventory control system and efforts to implement a new system.

·         Utah Department of Agriculture and Food

·         Committee discussion and potential action

 

3.    Medical Cannabis Policy Advisory Board Update

In accordance with UCA 4-41a-111(8), the policy advisory board may recommend to the appropriate legislative

committee whether the advisory board supports a change to medical cannabis statutes. The Working Group will

receive an update from the co-chairs of the policy advisory board and will have an opportunity to ask questions.

·         Medical Cannabis Policy Advisory Board

·         Public comment

·         Committee discussion and potential action

 

4.    Medical Cannabis Recommendation Processes

UCA 26B-4-213 currently prohibits a recommending medical provider from recommending medical cannabis to a patient through a virtual visit with certain exceptions. Recommendations are permitted through a virtual visit if the patient (1) is on hospice or has a terminal illness; (2) is a resident of an assisted living facility or nursing care facility; (3) has previously received a medical cannabis recommendation from the recommending medical provider through a face-to-face visit; or (4) is a current patient of the recommending medical provider and has met with the recommending medical provider face-to-face previously. The Working Group will consider the virtual visit recommendation policy.

·         Public comment

·         Committee discussion and potential action

 

5.    Medical Cannabis Qualifying Conditions

UCA 26B-4-203 lists the qualifying conditions for which a patient may receive a medical cannabis recommendation. The Working Group will consider the qualifying conditions list, the Compassionate Use Board, and a proposal to conduct a pilot program to use sleep as a qualifying condition.

·         Public comment

·         Committee discussion and potential action

 

 

6.    Medical Cannabis and Behavioral Health Services

Utah’s 12 county Local Mental Health and Substance Use Authorities (LMHAs) provide services to residents for mental health and substance use disorders. Services available through the LMHAs include clinical assessment, therapy (individual, family, group), psychosocial rehabilitation and skill development, case management, peer support services, respite, medication management, residential treatment, and crisis services. The Working Group will consider medical cannabis use by patients served by LMHAs and received feedback from providers on how medical cannabis use impacts LMHA service delivery.

·         Rylee Munns, Program Manager, Adult Substance Use Disorder Services, Southwest Behavioral Health Center

·         Public comment

·         Committee discussion and potential action

 

7.    Out-of-state Marijuana Entity Advertising

Utah statute places various parameters on how, what, and to whom state licensed medical cannabis entities are permitted to advertise. Concerns have been raised that out-of-state marijuana entities are currently placing advertisements in Utah for products that would be otherwise illegal within the state of Utah. The Working Group will consider these concerns and policy proposals to address these concerns.

·         Public comment

·         Committee discussion and potential action

 

8.    Controlled Substance Database Update

UCA 26B-4-202 requires the Department of Health and Human Services to coordinate with other state agencies to ensure that, among other things, dispensing information from a record that a medical cannabis pharmacy submits to the state electronic verification system under Subsection 4-41a-1102(3)(a)(ii) is communicated to the controlled substance database. The Working Group will receive an update on the implementation of this requirement.

·         Jeff Henrie, Controlled Substance Database Administrator, Division of Professional Licensing

·         Public comment

·         Committee discussion and potential action

 

9.    Medical Cannabis Use In Hospitals

As follow-up to its October 14, 2025, meeting, the Working Group will consider the possible benefits and drawbacks of medical cannabis use by terminally ill patients in healthcare facilities, and whether the federal reclassification of medical cannabis to a Schedule III controlled substance may impact this policy decision.

·         Public comment

·         Committee discussion and potential action

 

10. Federal Marijuana Scheduling Changes

As follow-up to its May 19, 2026, meeting, the Working Group will consider the status of this change and potential impacts to Utah’s medical cannabis program.

·         Public comment

·         Committee discussion and potential action

 

11. Adjourn